The responseof plasma leptin and feed intake to growth hormone administration in Holstein calves with different planes of nutrition

This study was conducted to observe the effect of the growth hormone (GH)/insulin-like growth factor-1(/IGF-1) axis on leptin and feed intake of 15 Holstein calves in three groups. One group was fed a normal diet (control); the second group, with high nutrition after low feeding with bovine growth hormone (bGH), and a third group, without high nutrition (saline) after low feeding. Each group was intramuscularly (i.m.) injected daily with bovine GH (200 µg kg-1 d-1) or saline solution for 10 d. No significant differences were found in the concentrations of plasma leptin over time for a 24-h period. Plasma leptin was decreased in both saline and GH groups during low and high nutrition regimes, respectively, while IGF-1 levels increased for both nutrition regimes (P < 0.05). With GH treatment during refeeding periods (P < 0.05), leptin levels increased and feed intake decreased; however, the plasma leptin levels slightly decreased with GH treatment during low feeding periods. The plasma IGF-1 concentration increased with GH administration during normal and refeeding periods (P < 0.05). These results indicate that the response of plasma leptin levels to GH varied according to the nutritional condition. In addition, the GH/IGF-1-induced increase in leptin production during the refeeding period may serve as a signal to reduce the feed intake or to increase dramatically after feed restriction in cattle. Key words: Feed intake, growth hormone, leptin, insulin-like growth factor-1, Holstein calves

Growth mechanism of tubular ZnO formed in aqueous solution

Tubular ZnO microstructural arrays were fabricated by a hydrothermal decomposition method. The dependence of the morphologies on the growth time and temperature was investigated in detail. An experiment was carried out to determine the mechanism of tubular ZnO formation. Our results showed that ZnO microtubes originated from an ageing process from ZnO microrods at a lower temperature (compared to the temperature when hydrothermal deposition of ZnO microrods was dominant) due to the preferential chemical dissolution of the metastable Zn-rich (0001) polar surfaces. A growth model was proposed based on the coexistence of hydrothermal deposition and dissolution of ZnO in the fabrication process.

Apoptosis and hormonal milieu in ductal system of normal prostate and benign prostatic hyperplasia

AIM

To study the apoptotic rate (AR) and the androgen and estrogen milieu in the proximal and distal ductal systems of prostate, in order to help exploring the effects of these factors on prostatic growth and the pathogenesis of benign prostatic hypertrophy (BPH).

METHODS

The proximal and distal ends of the ductal system were incised from 20 normal prostate as well as the hypertrophic prostate tissue from 20 patients with BPH. The AR was determined by the DNA end-labeling method and dihydrotestosterone (DHT) and estrodiol (E2), by radioimmunoassay.

RESULTS

There was no significant difference in DHT and E2 density between the proximal and distal ends of the ductal systems in normal prostate. E2 appeared to be higher in BPH than in normal prostatic tissues, but the difference was statistically insignificant. In normal prostatic tissue, the AR was significantly higher in the distal than in the proximal ends of the ductal system (P < 0.05), while the AR of the proximal ends was significantly higher (P < 0.01) than that in the BPH tissue. No significant correlation was noted between the DHT and E2 density and the AR both in the normal prostate and BPH tissues.

CONCLUSION

The paper is the first time describing a difference in AR in different regions of the ductal system of normal prostate, while the hormonal milieu is similar, indicating a functional inhomogeneity of these regions. A low AR in the proximal duct, where BPH originates, and an even lower AR in the BPH tissue, suggesting the participation of apoptosis in the BPH pathogenesis.

[Analyse of the site of lesion in auditory neuropathy]

OBJECTIVE

To analyze the clinic signs, the site of lesion and terminology of a kind of hearing loss which is characterized by speech hearing loss.

METHOD

The data of 11 patients were collected and analyzed including the clinic symptoms, pure tone audiometry, acoustic impedance audiometry, auditory brainstem response (ABR), electrocochleogram(ECochG), distortion product otoacoustic emission (DPOAE), CT/MRI.

RESULT

All these cases had following contradictory phenomena: Pure tone audiograms were low-frequency hearing loss; ABRs were absent or seriously abnormal, and ABR response threshold was worse than pure tone threshold and click subjective threshold; ECochG could be recorded in some patients; The stapes muscle reflex was absent; DPOAEs were normal or near normal, the average amplitude of low-frequency was higher than normal hearing group, but the average amplitude of high frequency was lower than normal hearing group; The imaging examination did not show any abnormality.

CONCLUSION

All data of this group show that the sites of lesion in most patients may be in lower brainstem, but the sites of lesion in some patients may be in the spiral ganglion of cochlea. The research of this disease should be continued.

Anticancer effect of Howiinol A and its mechanism of action

Howiinol A (GHM-10) is a kind of phenylethylene pyrone compounds isolated from Goniothalamus howii. By using the techniques of cell growth curve determination, MTT test, soft agar colony assay and experimental therapy of transplantable tumors in mice, it is found that GHM-10 exerts potent inhibitory effect on cancer cells but its influence on normal cells is relatively slight; the sensitivity of a drug-resistant cell line, KB/VCR 2000, to GHM-10 is similar to its parent cell line KB. Remarkable therapeutic effect can be seen in mice bearing H22 hepatoma and Lewis lung cancer and in mice with ascetic sarcoma 180 when GHM-10 is orally or intraperitoneally administered. The IC50s of L1210 cells treated with GHM-10 for 1 and 24 h are 6.85 and 3.32 micrograms.ml-1 respectively. The ratio of IC50 1 h and IC50 24 h is only 2.06, indicating that the action of GHM-10 is conformed to a cell cycle non-specific cytotoxic agent. By using trypan blue exclusive test and morphological examination, it is demonstrated that the main effect of GHM-10 is to inhibit the cell proliferation. Flow cytometery technique is used to analyze the cell cycle of L1210 cells. The results show that to some extent, GHM-10 blocks the cell cycle transition from G1 phase to S phase. By using [3H] labeled precursor incorporation technique, it is shown that GHM-10 significantly suppresses the biosynthesis of DNA, RNA and protein in L1210 cells, and the DNA synthesis is mostly affected. At 1 h after the cells were treated with GHM-10, these inhibitory effects have already been irreversible, suggesting that GHM-10 may cause structural damage on DNA molecules. However, GHM-10 is unable to intercalate into DNA molecules or to destroy its structure directly. By using single cell gel electrophoresis and alkaline elution technology, it is confirmed that GHM-10 causes DNA molecule damage and single strand breakage in L1210 cells. Further studies show that GHM-10 markedly inhibits DNA dehelix induced by DNA topoisomerase II both inside and outside the cells, indicating that GHM-10 is acting as an inhibitor of DNA topoisomerase II.

[Effect of HH07A, A derivative of hainanensine, on DNA polymerase I]

The effect of HH07A on DNA polymerase I in a cell free system was studied. The results showed that HH07A strongly inhibited the DNA synthesis catalyzed by DNA polymerase I in a dose dependent manner. Further results indicated that the DNA synthesis decreased significantly after DNA polymerase I was preincubated with HH07A. However, no change was found when DNA template was preincubated with HH07A. These results suggest that the inhibitory action of HH07A appeared to be on the enzyme molecules rather than on the DNA template.

[Studies on the anticancer effect of HH07A, a derivative of hainanensine]

The effect of HH07A on the growth of tumor cells in vitro was investigated using the techniques of cell growth curve determination and soft-agar colony-forming assay. The result showed that HH07A inhibited the growth of L1210 cells and HL-60 cells at a concentration of 1.5 micrograms.ml-1 and 4.0 micrograms.ml-1, respectively. Among the cells tested, L1210 cells were shown to be the most sensitive, followed by KB cells and HL-60 cells (with IC50 of 2.29, 4.13 and 4.36 micrograms.ml-1, respectively). Normal mouse granulocyte-macrophage progenitor cells (GM-CFC) were less sensitive to the drug (with IC50 of 11.15 micrograms.ml-1) as compared with the tumor cells. As they were exposed to HH07A 3.5 micrograms.ml-1 for 5 days, HL-60 cells did not show NBT reductive ability. Intraperitoneal injection of HH07A exerted inhibitory effect on the ascitic tumors of L1210 and S180 in mice. Oral or ip administration of HH07A also showed some effect on S180 solid tumors in mice.

Preparation and performance of cross-linked agar encapsulated activated charcoal (CAAC-III)

A technique is described to encapsulate activated charcoal for hemoperfusion to be used in an artificial liver support. Spherical activated charcoal was coated with agar and shaped in organic solvent, as well as cross-linked by epichlorohydrin (40-50 degrees C). The product withstood autoclaving at 121 degrees C for 0.5 hours, and had a good adsorption ability for compounds with molecular weight ranging from 113-5200. The adsorption kinetic showed pore diffusion limitation to compounds of small molecular weight, and film diffusion limitation to compounds of large molecular weight. Microparticles of charcoal release were greatly reduced, and within the permissible range according to the requirements in the U.S. Pharmacopeia (1985).

[Influence of radix Astragali on noise-caused changes in hepatic glycogen content in the rat]

It has been found that in rats exposed to a noise of 2kHz (mai frequency) and 103 dB(A) (potency) for 60 minutes, the hepatic glycogen content (HGC) is significantly higher than that of the control group unexposed to the noise (P less than 0.05), whereas in those treated with a prior ip Radix Astragali plus noise the HGC appears apparently lower than that of the noise group (P less than 0.05), very close to the control group (P greater than 0.2). This indicates that Radix Astragali might have some antinoise effect.

[Cytocidal action of homoharringtonine on L1210 cells in vitro]

The proliferation of L 1210 cells ceased rapidly after they were exposed to homoharringtonine (HH) 1 microgram/ml during exponential growth phase. However, 25.3% of the cells were still able to form colonies in soft agar if HH was removed after 24 h of incubation (the colony-forming efficiency for control cells was 62.5%). The clonogenic cells survived from the treatment were still sensitive to HH-continuous exposure. The IC50 of the treated and control cells were 15 and 20 ng/ml, respectively. Yet, the sensitivity of the treated cells to cytarabine decreased enormously. For instance, the survival rate of HH-treated cells remained at 100% level after they were exposed to cytarabine 4-8 micrograms/ml for 1 h, but only 40% control cells survived from the same treatment. When cells were continuously exposed to HH 0.4 micrograms/ml, the colony-forming efficiency decreased exponentially as a function of exposure time. The T1/2 of the clonogenic cells was about 18 h. The DNA contents in L 1210 cells was measured with a flow-cytometer. The results showed that the cell-cycle progress in all cells was interrupted by HH, regardless which phase they belonged to. So the cells seemed to be in a "frozen" state and the histogram unchanged.

Residual deficiencies in hemopoietic precursor cell populations after repeated irradiation of mice with x-rays or neutrons: dose-response relationships

Persistent reductions in the femoral content of hemopoietic colony-forming cells (CFU-S and GM-CFC) were observed after four doses of irradiation, delivered with three weeks between doses. In general, the reductions were dose dependent, and similar reductions were produced by single doses and repeated doses using the same total dose. After the lowest doses investigated, 4 X 0.75 Gy 300-kVp x-rays or 4 X 0.38 Gy 14.7-MeV neutrons, the recovered levels remained at 60%-80% of control for at least one year after irradiation. The relative biological effectiveness (RBE) of neutrons is about 2 for these long-term hemopoietic deficiencies.

A comparison of low and high dose-rate radiation for recipient mice in spleen-colony studies

Over the last 15 years, endogenous spleen-colony formation in our mice, following lethal irradiation, has increased to an unacceptable level. It has been found necessary, therefore, to introduce a new method of preparing recipient mice for spleen-colony studies. Irradiation with low dose-rate 60Cobalt gamma rays has been compared with high dose-rate linear accelerator electrons, and their effects on endogenous spleen colony formation compared with earlier X and gamma ray dose-response data. It was found that a large dose (13.5 Gy) of gamma rays results in fewer endogenous colonies than 8.5 Gy of electrons, yet because of its low dose rate (14.1 X 10(-3) Gy/min) it has a marked sparing of the intestinal tissue as measured by the intestinal microcolony technique. This in turn permits better survival and, therefore, a 'healthier' animal for spleen-colony work. Exogenous colony formation is also lower in the low dose-rate, gamma-irradiated recipients and this is shown to be due to a reduced spleen-seeding efficiency. It is concluded that very low dose-rate radiation is preferable for haemopoietic ablation, that a mouse colony requires constant monitoring for changes of endogenous spleen-colony formation and that the spleen-seeding efficiency of CFU-s depends on the irradiation technique used--there is no absolute value for a given strain of mouse.

A cellular analysis of residual hemopoietic deficiencies in mice after 4 repeated doses of 4.5 Gray X rays

A sub-optimal plateau in numbers of femoral stem-cells (CFU-S) in mice after 4 doses of 4.5 Gray X rays (each separated by 21 days), was shown to persist at 20-30% of control up to 1 year after the last dose, when about 50% of the mice had survived. The concentration of white cells in the blood was maintained persistently at about 70% of control, whereas the concentration of red cells was normal up to 4 months and then it declined to about 75% of control at 10 months after irradiation. Concentrations of some committed progenitor cells in the marrow (GM-CFC and ERC), which are capable of amplification cell divisions, were intermediate between the concentrations of marrow stem cells and mature blood cells in both the granuloid and the erythroid cell lineages, respectively. Hence increased amplification was a mechanism operating for a prolonged period in the production of numbers of mature cells. The numbers were subnormal, however, and this corresponded to only 1 extra amplification division on average. There was a slow decline after 6 months in the numbers of CFU-S, BFU-E and GM-CFC, and in the hematocrit, with reference to age-matched controls. The decline was due partly to a prevention of the natural increase in cell numbers in the marrow with the age of the mice, which was also seen with the femoral content of a stromal progenitor cell (CFU-F). A defect in the repeatedly-irradiated CFU-S population was detected as a persistent inability to produce colonies containing the same number of daughter CFU-S as contained in colonies derived from unirradiated marrow and assayed at the same time.

The response of stromal progenitor cells in mouse marrow to graded repeated doses of X rays or neutrons

After four repeated doses of 1.5 Gy X rays to mice (3-week intervals), the number of colonies containing fibroblasts that could be grown in vitro from femoral marrow recovered to control numbers by 80 days. After four higher doses, recovery was incomplete, and after four doses of 4.5 Gy, the number was half of the control level up to 1 year after irradiation. After four doses of 14.7 MeV neutrons, no threshold was detected for this late effect, and the RBE was about 2 at 4.5 Gy X rays and about 6 at 1.5 Gy X rays. The RBE for the acute effect on the stromal progenitor cells was also about 2 at 4.5 Gy X rays. The stromal progenitor cells could not be spared relative to hemopoietic stem cells (CFU-S) after neutrons, in contrast to the sparing observed after low-dose fractions of X rays. Experiments with local X irradiations of the leg, and with subcutaneous transplants of femora, revealed no significant recovery of stromal progenitor cells due to migration. However, recovery in situ could be enhanced slightly by marrow grafts i.v.

Stromal colonies from mouse marrow: characterization of cell types, optimization of plating efficiency and its effect on radiosensitivity

Modifications to the colony assay in vitro for stromal progenitor cells in mouse femoral marrow have been studied so as to optimize the efficiency of colony formation (CFE). The highest reproducible concentration achieved was about 30 colonies (containing fibroblasts, macrophages and endothelioid cells) per 10(6) nucleated marrow cells (range 20–50) in mice 3–4 months old, and higher by 50% in mice 14–15 months old. Each of many slight technical modifications could reduce these values by more than 30%. The importance of optimization was demonstrated by a reduced radiosensitivity when the CFE was reduced by a factor of 3 using alpha-medium stored at 4 degrees C for 15 days. The D0 value was 3.9 +/− 0.8 Gy compared to 1.6 +/− 0.1 Gy using freshly prepared medium, and this could be due to the selection of a radioresistant subpopulation. The modifications studied may partly explain the marked variations in CFE and in radiosensitivity reported in the literature.